MedInsights Unleashed

In this episode of MedInsights Unleashed, John Collins speaks with Patrick Coyle, MBA, about the often-overlooked journey patients face after receiving a prescription.The conversation explores the complex system behind drug access—including insurance coverage, copays, prior authorizations, and the role of pharmacies. Patrick provides insight into how financial and operational factors influence whether patients ultimately receive their prescribed treatment. The discussion also highlights key differences between branded and generic medications, the growing challenges in specialty therapies like oncology, and the importance of patient advocacy. This episode offers practical guidance for patients and caregivers on how to navigate the system, ask the right questions, and better understand the realities behind prescription access.

In this episode of MedInsights Unleashed, Professor Markus Peck-Radosavljević, MD, MBA—Professor of Medicine and Chairman of the Department of Internal Medicine & Gastroenterology at Klinikum Klagenfurt, Austria— discusses evolving treatment strategies in hepatocellular carcinoma (HCC).The conversation explores the changing role of transarterial chemoembolization (TACE) in intermediate-stage disease, emerging clinical evidence from studies such as REPLACEMENT Emerald-1 and LEAP-012, and how new systemic and immunotherapy approaches are reshaping treatment decisions. The discussion also highlights the importance of curative opportunities, multidisciplinary care, and maintaining overall survival as the most meaningful endpoint in liver cancer treatment.

In this episode of MedInsights Unleashed, the discussion focuses on advanced chronic spine pain and when surgery becomes part of the care pathway. Dr. Rohan R. Lall, neurosurgeon at M Health Fairview University of Minnesota Medical Center, shares clinical perspective on evolving surgical approaches for patients with severe degeneration, instability, and chronic nerve-related pain. The conversation explores electrically enhanced transforaminal lumbar interbody fusion (e-TLIF), which combines spinal stabilization with targeted nerve stimulation, as well as broader trends in non-opioid pain management, minimally invasive surgery, robotics, and AI shaping modern spine care.

Dr. Lori Wirth, MD—Elizabeth and Michael Ruane Chair of Endocrine Oncology; Medical Director of the Massachusetts General Hospital Center for Head and Neck Cancers; and Professor of Medicine at Harvard Medical School—joins MedInsights Unleashed to discuss modern thyroid cancer care. She explores differentiated, medullary, and anaplastic disease; advances in diagnosis and treatment; the role of genomic testing, including BRAF V600E and RET; and the use of active surveillance for selected patients. Dr. Wirth underscores the importance of individualized care and shared decision-making, offering clear, practical insights for patients, caregivers, and clinicians navigating an evolving thyroid cancer landscape.

In this MedInsights Unleashed episode, we explore an emerging treatment for chronic degenerative disc disease called Hydrafil.Our guests are Bill Niland, CEO of ReGelTec Inc., and Dr. Anthony Lowman, PhD, Professor of Biomedical Engineering and Co-Founder/Chief Medical Officer at ReGelTec. They walk us through the science, creation, and development of this injectable hydrogel technology. Hydrafil is designed to help patients with lumbar back pain by restoring hydration and pressure inside the spinal disc, supporting its structure, and potentially reducing inflammation and pain.ReGelTec has launched its pivotal HYDRAFIL-D Study, a multicenter, randomized U.S. trial enrolling ~225 patients. For details, visit ClinicalTrials.gov and search: Degenerative Disc Disease + Hydrafil (NCT06011551 and NCT04984629).

In this episode of MedInsights Unleashed, Professor Pierre Gholam, MD., FAASLD, AGAF, returns to explore the transformative potential of GLP1-based therapies beyond diabetes and obesity. The discussion highlights how these drugs may play a groundbreaking role in **cancer prevention—particularly liver cancer—**by addressing the root causes of metabolic dysfunction, a growing public health crisis affecting millions of Americans. Prof. Gholam emphasizes the need for multidisciplinary collaboration among hepatologists, endocrinologists, and primary care providers to improve early detection and treatment of fatty liver disease through noninvasive diagnostics and proactive referral pathways. The episode also looks ahead to emerging oral and multi-agonist GLP1 therapies, marking a new frontier in personalized metabolic and oncologic care.

We’re honored to share a powerful new episode featuring Dr. Pierre Gholam, MD, FAASLD, AGAF—Professor of Medicine at Case Western Reserve University and Director of the Hepatobiliary Multidisciplinary Team at University Hospitals Seidman Cancer Center. With clarity and compassion, Dr. Gholam explores the complex and evolving nature of liver cancer, tracing its historical roots in viral hepatitis to today’s sharp rise in cases driven by fatty liver disease and alcohol use. He highlights both the breakthroughs and ongoing challenges in hepatocellular carcinoma (HCC) care—from early tyrosine kinase inhibitors to the promise of immune checkpoint inhibitors—while underscoring the critical need for improved screening strategies. Throughout the discussion, Dr. Gholam emphasizes the central role hepatologists play in managing HCC, from diagnosis to therapy.

We are privileged to have Dr. Ari Rosenberg, MD, and Dr. Maha Elsebaie, MD, MSc, from the University of Chicago, join us to discuss groundbreaking research in neoadjuvant head and neck cancer treatment. This episode explores how circulating HPV DNA, measured through a simple blood test, is emerging as a powerful tool to guide therapy decisions, personalize treatment, and potentially reduce the need for aggressive surgery or radiation.The discussion highlights early results from trials combining immunotherapy and chemotherapy before standard treatment, showing promising improvements in tumor response while reducing long-term side effects. This research is shaping the future of HPV-related head and neck cancer care and could change how clinicians plan treatments—bringing us closer to a more precise and less invasive approach.

Groundbreaking research presented at ASCO with Dr. Elinor Barsh, MD, and Dr. Jacob Keeling, MD, focuses on advances in immunotherapy for CTLA-4 resistant melanoma. This episode highlights the importance of recent progress, including the Phase I study of the antibody–drug conjugate ozuriftamab vedotin. Dr. Barsh and Dr. Keeling discuss new clinical trial data, evolving treatment pathways, and the significant reduction in mortality rates achieved with novel therapies. Their collaboration with the Sarah Cannon Research Institute underscores how innovative research can transform patient outcomes making melanoma more manageable despite its aggressive nature.

Dr. Sharlene Gill, MD, joins the MedInsights Unleashed podcast to discuss the Challenge Study's promising results on exercise in cancer care. Conducted over 17 years, the study revealed that colon cancer patients engaging in structured exercise post-treatment exhibited improved survival rates. The trial involved a comprehensive three-year program incorporating both in-person and virtual components, emphasizing physical activity alongside psychological support. Published in the New England Journal of Medicine (Structured Exercise after Adjuvant Chemotherapy for Colon Cancer) these findings could shift cancer treatment paradigms, advocating for the inclusion of formal exercise programs in post-chemotherapy care to enhance life expectancy and recovery in cancer patients.

In this episode of MedInsights Unleashed, Dr. Ari Goldman, MD, FAAOS, and Lewis Collins, OPA-C, ATC, OTC, from the Northwell Health Orthopedic Trauma and Surgery Team, uncover the facts on knee replacements. The discussion kicks off with a detailed look at knee anatomy and the factors leading to knee replacements, such as arthritis and genetic predispositions. The episode delves into the importance of maintaining knee health through exercise and weight management. They also explore how alignment issues elsewhere in the body can impact knee integrity and the outcomes of replacement surgery. The episode wraps up with insights into dietary considerations for bone quality and joint health.

Professor Philip A. Philip, MD, PhD, FRCP, Professor of Medical Oncology at Wayne State University School of Medicine and the Henry Ford Cancer Institute, returns to the MedInsights Unleashed podcast discusses the intricate topic of neuroendocrine tumors(NETs), including their rarity, the non-aggressive nature of many cases, and their potential functional characteristics. Prof. Phillip clarifies common misconceptions, advising listeners on the crucial role of accurate diagnosis and the use of grading systems to assess tumor aggressiveness. This episode not only benefits patients seeking understanding of their condition but also serves as a valuable resource for healthcare professionals dealing with these complex cancers.

In this episode of MedInsights Unleashed, Dr. Kriti Dhamija, MD, a second-year resident in the Department of Internal Medicine at Allegheny Health Network, Pittsburgh, Pennsylvania, USA, challenges the misconceptions around palliative care, particularly in pancreatic cancer. She explains why palliative care should begin at diagnosis, not at the end of life, and how early referral can reduce ER visits, hospital stays, and ICU admissions. Dr. Dhamija also explores the role of multidisciplinary teams, tackles persistent stigmas, and highlights how even resource-limited settings can improve care using team-based approaches and free guidelines. A must-listen for clinicians, patients, caregivers, and students alike.

In a recent episode of MedInsights Unleashed, Dr. Danny Rischin, MD, medical oncologist/clinician researcher at the Peter MacCallum Cancer Centre and Professor, Sir Peter MacCallum Department of Oncology, University of Melbourne, discusses the groundbreaking C-POST study focused on cutaneous squamous cell cancer. By utilizing the immunotherapy drug, cemiplimab, the study achieves a 68% reduction in the risk of recurrence, marking a significant step forward in adjuvant cancer therapy. Dr. Rischin explains the study's meticulous approach to identifying high-risk patients and its impressive 87% disease-free survival rate at two years. He also discusses the role of multidisciplinary care in effectively managing complex cancer cases, emphasizing the need for continued research in uncovering reliable biomarkers. 

In this episode of MedInsights Unleashed, Professor Philip A. Philip, MD, PhD, FRCP, Professor of Medical Oncology at Wayne State University School of Medicine and the Henry Ford Cancer Institute, shares vital insights into one of the most challenging cancers to detect and treat—pancreatic cancer. He highlights the urgent need for early recognition of symptoms and the growing understanding of genetic risks, including BRCA mutations and family history.The discussion also covers emerging research into KRAS, common DNA mutation in tumors that is playing a major role in changing future targeted treatment strategies. With perspectives from both U.S. and global healthcare systems, this episode emphasizes the power of awareness, timely action, and the promise of personalized medicine in improving outcomes for patients.

In this hard-hitting episode of MedInsights Unleashed, we tackle the escalating crisis of drug-related medical emergencies with guest speaker Eric Prach, MAS, BPsych—an EMT and police officer on the frontlines. This episode uncovers the harsh realities of fentanyl-laced overdoses, the rise of synthetic additives like Xylazine, and the increasing concern over Kratom use among young individuals.Eric provides critical insights into the life-saving role of Narcan, the challenges EMS teams face in overdose response, and the alarming prevalence of drug use in schools. As volunteer EMT numbers decline, hybrid staffing models are becoming the new norm. This conversation serves as a wake-up call, underscoring the urgent need for awareness, prevention, and preparedness in combating the street drug epidemic.4o

Episode Summary:This is the second episode in our series on colorectal cancer. In this episode of MedInsights Unleashed, we sit down with Prof. Paulo Hoff, MD, PhD, from the University of São Paulo, Brazil, to discuss the latest developments in colorectal cancer treatment. With cases increasing, especially among younger adults, the conversation underscores the importance of early screening and detection. Prof. Hoff explains how tumor location—right vs. left side—affects treatment strategies, the role of genetic markers in guiding decisions, and how immunotherapy is shaping new treatment options. Listeners will gain a clearer understanding of molecular profiling, personalized care, and what these advancements mean for patients facing colorectal cancer.

Osteoporosis is often viewed as a women’s disease, but in this episode of MedInsights Unleashed, Dr. Tom Forfa, MBBS, reveals why men are also at serious risk. A retired physician and osteoporosis educator from Queensland, Australia, Dr. Forfa shares his personal journey, from multiple fractures to a delayed diagnosis, highlighting the need for early screening and awareness.This episode uncovers misconceptions, risk factors, and treatment options, including an unexpected dietary ally—prunes. Recent research suggests that daily prune consumption may help maintain bone density and support fracture healing, making it a promising nonpharmacologic approach to osteoporosis prevention.👉 If you think osteoporosis only affects women, think again.

In this latest episode of MedInsights Unleashed, we are delighted to welcome Dr. Paulo Hoff, MD, PhD, Professor of Clinical Oncology at the Department of Radiology and Oncology, University of São Paulo. Dr. Hoff discusses the rising incidence of colorectal cancer in younger populations, highlighting key risk factors including poor diet, sedentary lifestyle, and obesity. He emphasizes the critical importance of beginning regular screening at age 45.The discussion covers the complete treatment journey, from initial diagnosis through staging—which determines both local and distant tumor spread—to help create optimal treatment plans. Dr. Hoff explains that some patients may require temporary or permanent colostomy procedures.A significant focus is placed on the emerging total neoadjuvant treatment (TNT) approach, which administers all chemotherapy and radiation before surgery to improve outcomes. The episode concludes by emphasizing the value of collaborative care, bringing together different oncology specialists for comprehensive treatment

In this MedInsights Unleashed episode, Dr. Christine Simmons, MD, Associate Professor in the Faculty of Medicine at UBC (University of British Columbia) and specialist in breast cancer and sarcoma, provides an in-depth exploration of the breast cancer journey, focusing on diagnosis, staging, and cutting-edge treatments for triple-negative breast cancer. She discusses the critical role of subtype differentiation and personalized care, with a particular emphasis on advancements in managing triple-negative breast cancer. Highlighting the transformative potential of immunotherapy, Dr. Simmons likens it to removing the "invisibility cloak" from cancer cells, enabling the immune system to target them effectively. Balancing innovation with caution, she also addresses the possible side effects of these treatments, offering a nuanced perspective on this rapidly evolving field. This episode is an essential resource for understanding the challenges and breakthroughs in breast cancer care.

In this MedInsights Unleashed episode, Dr Christine Simmons MD, Associate Professor in the Faculty of Medicine at UBC (University of British Columbia) and specialist in breast cancer and sarcoma, discusses breast cancer awareness, emphasizing the importance of regular screenings for early detection—especially post-COVID-19, as screening rates have significantly dropped. Early detection leads to better outcomes and less aggressive treatments. Dr. Simmons highlights that breast cancer is not exclusively a women’s issue, as men can develop it too. Additionally, she underscores the role of genetics, such as BRCA mutations, in increasing breast cancer risk. Preventative strategies like regular exercise, limiting alcohol intake, and a healthy diet are important in preventing breast cancer. She discusses the role of low-dose tamoxifen for high-risk patients, and for those with significant risk, preventive mastectomy can reduce cancer likelihood. Diagnostic imaging like mammograms and ultrasounds are essential to distinguish benign from malignant growths, often followed by a biopsy. Dr. Simmons’s insights encourage proactive health measures and vigilance in cancer prevention.

Elen Baloyan, MD, Oncology Fellow at Yeolyan Hematology and Oncology Center in Yerevan, Armenia, shares her insightful journey in this MedInsights Unleashed podcast episode. She addresses the financial toxicity affecting both doctors and patients in Armenia, which often leads to treatment refusals and late diagnoses due to high costs. Despite government efforts to support cancer care, the financial burden remains significant. Elen discusses the future of clinical trial development and the hope it brings to patients through the Immune Oncology Research Institute in Armenia. Elen's diverse roles, from medical practice to managing editor at OncoDaily, highlight pressing issues and her commitment to finding solutions. This episode emphasizes the need for greater financial support and education in the medical field.

In this episode of MedInsights Unleashed, Dr. Oliver Bathe MD FRCSC, Professor of Surgery and Oncology University, CEO Qualisure Diagnostics Inc. discusses his journey from surgical oncology to pioneering precision cancer care. He delves into the role of machine learning in analyzing vast genomic databases to personalize treatment and improve patient outcomes. Dr. Bathe shares personal insights, emphasizing the importance of tailoring cancer therapies to individual patients. The podcast explores the creation and application of diagnostic tests, like those for thyroid cancer, which offer more targeted treatment options and hope for patients confronting a complex healthcare landscape. Qualisure Diagnostics Inc contact information:Oliver F. Bathe, MD - CEO & Founder3655 36th Street NW Calgary, Alberta T2L 1Y8p: +1 403.614.7124e:  [email protected] | www.qualisuredx.com

In this MedInsights Unleashed episode, Dr. Ari Rosenberg from University Chicago Medical Center, delves into the complexities and advancements in the treatment of head and neck cancers. Despite the recurrence and resistance these cancers often develop, immunotherapy has marked a significant breakthrough, especially in releasing the immune system's brakes. Although its introduction in early-stage cancer remains elusive, ongoing trials indicate potential when combined with chemotherapy pre-treatment. Dr. Rosenberg highlights innovative therapies, including targeting HPV-specific cancer proteins and antibody drug conjugates, which hold promise in enhancing treatment efficacy. These cutting-edge strategies aim to outmaneuver resistant cancer cells, providing hope for improved survival rates.

In this episode Professor Philippe Merle explains the interplay between chronic liver conditions and the development of HCC. The conversation highlights the significance of early diagnosis and consistent patient monitoring to catch the disease in its nascent stages. Professor Merle also discusses the evolving landscape of HCC treatments, including innovative therapies and the benefits of a multidisciplinary medical team in managing complex cases.

In this episode of Med Insights Unleashed, hosts Zee and John welcome Michael Staehler MD Ph.D, Professor of Urology at the University of Munich and Head the Interdisciplinary Center for Renal Tumors at Ludwig-Maximilian University, Munich. to discuss renal cell carcinoma. He explains how patient selection and managing side effects, including sexual dysfunction, play critical roles in effective cancer treatment. The conversation also delves into the balance between drug efficacy and patient experience, highlighting the importance of patient communication and personalized care in clinical practice.

In this episode, hosts Zahra and John welcome Dr. Ari Rosenberg from University Chicago Medical Center, to explore head and neck cancer, a disease affecting nearly 900,000 people annually worldwide. Dr. Rosenberg delves into the complexities of diagnosing and treating cancers in the head and neck region. The discussion highlights the significant role of HPV, particularly in oropharynx cancers, and the promising impact of HPV vaccination. Emphasizing early detection, Dr. Rosenberg also shares insights on the importance of regular dental check-ups in identifying potential cancerous lesions.

In this episode, Professor Escudier from Gustave Roussy, a major cancer center in Paris France, discusses the advances in kidney cancer treatment over the past 30 years. Professor Escudier discusses the significance of the Keynote 564, the first positive trial in adjuvant renal cell cancer. He explains how these findings impact first-line treatment decisions for metastatic kidney cancer. He discusses the differences between cure, complete response and the role of the MDT, clinical and pathological biomarkers in treatment selection. Professor Escudier especially covers the questions that he patient should their doctors concerning their renal cancer and defines the differences between Clear Cell and Non-Clear Cell renal cancer treatment outcomes and expectations.

In this episode, Dr. Ariel Goldman and Lewis Collins discuss the advancements in hip fracture care. They highlight the urgent need for timely surgical intervention and reveal how these practices have successfully reduced complications and mortality rates. Focusing on the aging population and osteoporosis, they stress the importance of understanding risk factors and prevention. They compare exercise forms, such as Tai Chi, to other physical therapy methods in preventing hip fractures and emphasize the benefits of weight-bearing exercises. Tai Chi, in particular, is highlighted for its role in increasing strength and bone density, contributing to early treatment success. This episode provides valuable insights into the benefits of immediate care, pain management solutions like nerve blocks, and the role of research in improving patient outcomes globally.

In this episode, Prof Galle, a hepatologist and Professor of Medicine at University Medical Center Mainz, Germany, has an in-depth conversation with co-hosts Zee and John of MedInsights Unleashed on the late breaking data, CM9DW, presented at ASCO 2024. The episode covers:- **Cutting-Edge Therapies:** Explore the transformation in HCC treatment from surgery and transplantation to the latest immunotherapies. Discover how IV therapies demonstrate superior efficacy and manageable toxicity compared to oral options. - **Checkmate 9DW Trial Insights:** Get an in-depth analysis of the pivotal Checkmate 9DW trial, comparing immunotherapy agents (Nivolumab and Ipilimumab) with tyrosine kinase inhibitors (lenvatinib or sorafenib). Learn about the trial's diverse patient population and the critical role of alpha fetoprotein as a prognostic marker. - **Combination vs. Monotherapy:** Hear why combination therapies are setting new benchmarks in complete response rates and overall survival, offering new hope for liver cancer patients. - **Multidisciplinary Approach:** Understand the crucial role of multidisciplinary teams in navigating complex decisions involving liver transplantation, intra-arterial therapies, and systemic treatments. - **Patient Management and Outcomes:** Discover the significance of early side-effect management and patient education in improving long-term outcomes, reducing treatment visits, and enhancing quality of life.

Professor Markus Peck-Radosavljevic, MD MBA, is Professor of Medicine and Chairman at the Department of Internal Medicine & Gastroenterology (IMuG) at Klinikum Klagenfurt in Austria. A renowned gastroenterologist and hepatologist, he discusses the importance of understanding risks in medical treatments, clear communication, and considering patient preferences in treatment decisions. Professor Peck addresses challenges in patient selection for clinical trials and the impact on access to innovative treatments. Professor Peck also emphasizes the role of second opinions, the importance of trust in the patient-physician relationship, and the expertise required for state-of-the-art care. He touches on the complexities of information overload and the emerging role of artificial intelligence in healthcare decision-making.

This podcast episode focuses on radioembolization and its implications in liver cancer treatment. Professor Edward Kim, Director of Interventional Oncology at Mount Sinai Health Systems, provides insights into the use of radioembolization, a minimally invasive procedure that delivers radiation directly to liver tumors. He discusses its utilization across different stages of primary liver cancer, from curative intent therapies in early stages to palliative care in advanced stages. Professor Kim emphasizes the importance of a multidisciplinary approach in liver cancer care, where different specialists collaborate to determine the best treatment options for each patient. The episode also touches on the combination of radioembolization with systemic therapy, ongoing trials and studies, as well as the challenges and opportunities in liver cancer treatment. Overall, this episode offers valuable information and hope for liver cancer patients and their caregivers.

This transcript explores the challenges faced by both physicians and patients in accessing treatment. Professor Vogel discusses the differences in treatment access between Germany and Canada, having experienced both healthcare systems. He highlights the restrictive criteria for liver transplantation in Germany and the limited availability of certain therapies in Canada, particularly for rare cancers like cholangiocarcinoma. The discussion delves into the ethical implications of withholding potentially life-saving treatments and the need for a more streamlined and patient-centered approach to reimbursement. Financial toxicity is also examined, as well as the role of patient advocacy in driving change and ensuring timely access to treatment. The transcript concludes with a call to action for patients and healthcare professionals to advocate for improved access to the right treatment at the right time.

MedInsights Unleashed is an exciting new podcast aimed at providing valuable information and insights for patients and healthcare professionals.In this first episode, hosts Zahra and John are joined by Professor Arndt Vogel to discuss key data from the adjuvant setting of liver cancer. They talk about the challenges of liver cancer treatment, the high mortality rate associated with the disease, and the progress made in recent years. Professor Vogel provides an overview of the IMbrave 050 study, which was designed to investigate the efficacy of an adjuvant treatment combination of the checkpoint inhibitor atezolizumab and the targeted therapy bevacizumab in delaying or preventing recurrence compared with active surveillance. The study shows promising results in terms of improved recurrence-free survival, but longer follow up is needed to determine its impact on overall survival. The conversation also touches on the safety profile of the treatment and the importance of multidisciplinary teams in decision-making.

Trailer for MedInsights Unleashed with Zee and John, starring co-hosts Zahra Ramji (aka Zee) and John Collins

In their debut episode, John Collins and Zahra, also known as Zee, introduce themselves and their backgrounds in the pharmaceutical industry and healthcare. With a focus on filling the void between physicians and patients, they share their passion for improving patient outcomes, particularly in underserved areas like liver cancer. John draws parallels from his experience as an EMS first responder, emphasizing the importance of rapid knowledge transfer in saving lives. Zahra discusses her work in clinical trials and oncology, highlighting the desire to make a tangible difference in patients' lives. Together, they embark on a journey through the MedInsights Unleashed podcast to uncover global healthcare trends and empower patients with valuable insights.